SCHEMBL8947546

SCHEMBL8947546

CCOC(=O)C1=CC=CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 1/20 0.42
CA12 O43570 6/20 0.41
CA1 P00915 6/20 0.41
CA2 P00918 6/20 0.41
CA7 P43166 6/20 0.41
CA9 Q16790 6/20 0.41
CA14 Q9ULX7 6/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
MAPT P10636 3/20 0.40
CYP1A2 P05177 2/20 0.40
LMNA P02545 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ALOX15 P16050 1/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28417053 1.00 TSHR (0.48) TSHRALDH1A1HSD17B10CA12CA1
SCHEMBL9039761 0.92 TSHR (0.46) TSHRALDH1A1HSD17B10CA12CA1
SCHEMBL28408947 0.85 ALDH1A1 (0.52) TSHRALDH1A1HSD17B10ESR1LMNA
SCHEMBL14384187 0.84 TSHR (0.38) TSHRALDH1A1HSD17B10CA12CA1
SCHEMBL5187673 0.83 TSHR (0.40) TSHRALDH1A1HSD17B10CA12CA1
SCHEMBL28890928 0.82 TSHR (0.54) TSHRALDH1A1HSD17B10ESR1CYP1A2
SCHEMBL28891457 0.80 TSHR (0.58) TSHRALDH1A1HSD17B10ESR1MAPT
SCHEMBL28412005 0.80 TSHR (0.58) TSHRALDH1A1HSD17B10ESR1MAPT
SCHEMBL28417766 0.80 TSHR (0.58) TSHRALDH1A1HSD17B10ESR1MAPT
SCHEMBL28412415 0.80 TSHR (0.58) TSHRALDH1A1HSD17B10ESR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11779015-B2 Pesticide compositions FUNDACIÓ CENTRE DE REGULACIÓ GENÓMICA (ES) 2023-10-10 US disclosed
CN-109970708-B Cannabinoid receptor modulators 艾尼纳制药公司 2022-06-21 CN disclosed
US-20200359621-A1 PESTICIDE COMPOSITIONS FUNDACIÓ CENTRE DE REGULACIÓ GENÒMICA (ES) 2020-11-19 US disclosed
CN-106632744-B Propylene polymerization catalyst, preparation method and application 北京化工大学 2020-05-15 CN disclosed
EP-3488695-A1 PESTICIDE COMPOSITIONS Fundació Centre de Regulació Genòmica (ES) 2019-05-29 EP disclosed
US-20180072726-A9 NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2018-03-15 US disclosed
US-9725452-B2 Substituted indoles and pyrroles as RIP kinase inhibitors PRESIDENTS AND FELLOWS OF HARVARD COLLEGE (US) 2017-08-08 US disclosed
US-20160068531-A1 NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2016-03-10 US disclosed
US-20160024098-A1 HYBRID NECROPTOSIS INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-01-28 US disclosed
US-9200008-B2 Heterocyclic compound and p27Kip1 degradation inhibitor ASKA PHARMACEUTICAL CO., LTD. (JP) 2015-12-01 US disclosed
US-20140323489-A1 HYBRID NECROPTOSIS INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-10-30 US disclosed
US-20130079306-A1 HETEROCYCLIC COMPOUND AND p27Kip1 DEGRADATION INHIBITOR ASKA PHARMACEUTICAL CO., LTD. (JP) 2013-03-28 US disclosed
US-20120077814-A1 SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES WANG ZHONG (US) 2012-03-29 US disclosed
US-7399782-B2 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases UNIVERSITY OF NORTH CAROLINA AT WILMINGTON (US) 2008-07-15 US disclosed
US-5565500-A CURED PRODUCT OBTAINED BY HEATING MIXTURE OF EPOXY RESIN, VINYL ETHER OR VINYL ESTER, IRON-CONTAINING METALLOCENE CIBA-GEIGY CORPORATION (US) 1996-10-15 US disclosed
US-5371259-A Photoinitiators CIBA-GEIGY CORPORATION (US) 1994-12-06 US disclosed
US-5091439-A Using arene iron complex as curing agent CIBA-GEIGY CORPORATION (US) 1992-02-25 US disclosed
US-5073476-A Containing iron aromatic complex and oxidizer CIBA-GEIGY CORPORATION (US) 1991-12-17 US disclosed
US-4957946-A FERROCENE TYPE COMPLEXES, EPOXY RESINS, VINYL ETHERS AND VINYL ESTERS CIGA-GEIGY CORPORATION (US) 1990-09-18 US disclosed
US-4861806-A PHOTOPOLYMERIZATION, LATENCY CIBA-GEIGY CORPORATION (US) 1989-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200359621-A1 PESTICIDE COMPOSITIONS ADH1C, DDT, AKR1C3 TSHR 3247/4885ALDH1A1 35/4885HSD17B10 22/4885
US-20160068531-A1 NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION ZC3HAV1, IDO1, AZI2 TSHR 1187/4885ALDH1A1 1795/4885HSD17B10 3620/4885
US-20140323489-A1 HYBRID NECROPTOSIS INHIBITORS RIPK3, RIPK1, RIPK4 TSHR 4186/4885ALDH1A1 4684/4885HSD17B10 3567/4885
US-20130079306-A1 HETEROCYCLIC COMPOUND AND p27Kip1 DEGRADATION INHIBITOR CDKN1A, SKP2, CCNI TSHR 4485/4885ALDH1A1 1594/4885HSD17B10 2262/4885
US-20120077814-A1 SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES NEDD8, NAE1, UBA3 TSHR 4279/4885ALDH1A1 398/4885HSD17B10 1884/4885
US-20160024098-A1 HYBRID NECROPTOSIS INHIBITORS RIPK3, RIPK1, RIPK4 TSHR 4186/4885ALDH1A1 4684/4885HSD17B10 3567/4885
US-20180072726-A9 NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION ZC3HAV1, IDO1, AZI2 TSHR 1187/4885ALDH1A1 1795/4885HSD17B10 3620/4885
US-11779015-B2 Pesticide compositions ADH1C, DDT, AKR1C3 TSHR 3247/4885ALDH1A1 35/4885HSD17B10 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.